Glycophos
Product Images NDC 63323-241

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Glycophos (NDC 63323-241). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Fresenius Kabi Usa, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Comparison

Comparison
This appears to be a list of product codes and their corresponding volume (i.e., 1sm, 15mL, 50mL) and manufacturers (e.g., Pfizer, Fresenius Kabi, American Regent) for various medical products. However, it is not clear what the context or purpose of this list is.*
FDA Label Image

Vial-lyv1963 (Glycophos Figure 1 Vial Lv1963)

Vial-lyv1963 (Glycophos Figure 1 Vial Lv1963)
Glycophos™ is a sterile concentrate used for injection after dilution. It contains 1.0 mmol of phosphate and 2.0 mmol of sodium per 1 mL. It is indicated that it should not be injected undiluted. The manufacturer is Fresenius Kabi, and the batch number is LYV 1963 01-67-07-005. The expiration date is not available.*
FDA Label Image

Carton-lyv1963 (Glycophos Figure 2 Carton Lyv1963)

Carton-lyv1963 (Glycophos Figure 2 Carton Lyv1963)
Glycophos is a sterile concentrate in 20 ml vials manufactured by Fresenius Kabi in Norway and distributed by their division in Sweden. It is an additive meant to be mixed in infusion fluids and contains sodium glycerophosphate, hydrochloric acid, and water for injections. Each mL contains 1.0 mmol of phosphate and 2.0 mmol of Sodium. The warning advises against injecting undiluted and keeping it away from children while storing below 25 °C and not freezing. The document includes a manufacturing date and lot number with specific use-before instructions.*
FDA Label Image

Market

Market
Glycophos is an organic phosphate solution with 1 mMol of phosphate per 1 mL, which is different from the inorganic phosphate injection products marketed in the U.S. with 3 mMol of phosphate per 1 mL. It does not contain preservatives, is intended for single-use with strict aseptic technique, and is contraindicated for patients with particular medical conditions. The aluminum content of Glycophos is less than 550 meg/L, and its container closure is not made from natural rubber latex. The product comparison table highlights the key differences in strength, formulation, and labeling between phosphate injection products currently available in the U.S. and Glycophos. The barcodes on Glycophos products are not appropriate for scanning systems in the United States and should not be used. Instead, alternative procedures must be followed to ensure that the correct drug product is given to individual patients.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.